AlloCure Raises $14.5 Million

AlloCure, a cell therapy company focused on acute kidney injury, has raised $14.5 million in Series A funding. SV Life Sciences led the round, and was joined by Novo AS. AlloCure has offices in both Germany and Salt Lake City. 

PRESS RELEASE

AlloCure Inc.,